Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects

Withdrawn before enrolling · Phase 1

Conditions studied: Healthy

In brief

The primary objective of this trial is to investigate the relative bioavailability and pharmacokinetics in plasma and whole blood of BI 691751 administered as a single dose with and without food in healthy male subjects.

Key facts

Study ID
NCT02175238
Run by
Boehringer Ingelheim
People needed
0
Starts
2014-07-01
Expected to finish
2014-10-01
Last updated by the study team
2014-07-24

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.